Discordance of positive immunohistochemical results among different primary HER2 antibodies used in breast cancer: A comparison between Histofine® HER2 Kit (MONO) SV2-61Î³ antibody and Ventana I-VIEW PATHWAY&#8482; HER2 4B5 antibody.

Fujita, Kei; Yao, Takashi

Discordance of positive immunohistochemical results among different primary HER2 antibodies used in breast cancer: A comparison between Histofine® HER2 Kit (MONO) SV2-61Î³ antibody and Ventana I-VIEW PATHWAY™ HER2 4B5 antibody.

Fujita, Kei; Yao, Takashi.

Afiliação

Fujita K; Juntendo University Graduate School of Medicine, Department of Human Pathology, Tokyo, Japan. Electronic address: kfujita@juntendo.ac.jp.
Yao T; Juntendo University Graduate School of Medicine, Department of Human Pathology, Tokyo, Japan.

Rev Esp Patol ; 55(4): 222-229, 2022.

Article em En | MEDLINE | ID: mdl-36154727

Assuntos

Neoplasias da Mama; Anticorpos Monoclonais; Feminino; Humanos; Imuno-Histoquímica; Hibridização in Situ Fluorescente; Receptor ErbB-2

Palavras-chave

4B5; HER2; SV2-61Î³; Trastuzumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2022 Tipo de documento: Article